688 related articles for article (PubMed ID: 21173220)
1. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.
Janeway KA; Kim SY; Lodish M; Nosé V; Rustin P; Gaal J; Dahia PL; Liegl B; Ball ER; Raygada M; Lai AH; Kelly L; Hornick JL; ; O'Sullivan M; de Krijger RR; Dinjens WN; Demetri GD; Antonescu CR; Fletcher JA; Helman L; Stratakis CA
Proc Natl Acad Sci U S A; 2011 Jan; 108(1):314-8. PubMed ID: 21173220
[TBL] [Abstract][Full Text] [Related]
2. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.
Celestino R; Lima J; Faustino A; Vinagre J; Máximo V; Gouveia A; Soares P; Lopes JM
Eur J Hum Genet; 2013 May; 21(5):503-10. PubMed ID: 22948025
[TBL] [Abstract][Full Text] [Related]
3. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.
Pantaleo MA; Astolfi A; Urbini M; Nannini M; Paterini P; Indio V; Saponara M; Formica S; Ceccarelli C; Casadio R; Rossi G; Bertolini F; Santini D; Pirini MG; Fiorentino M; Basso U; Biasco G;
Eur J Hum Genet; 2014 Jan; 22(1):32-9. PubMed ID: 23612575
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
[TBL] [Abstract][Full Text] [Related]
5. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.
Miettinen M; Killian JK; Wang ZF; Lasota J; Lau C; Jones L; Walker R; Pineda M; Zhu YJ; Kim SY; Helman L; Meltzer P
Am J Surg Pathol; 2013 Feb; 37(2):234-40. PubMed ID: 23282968
[TBL] [Abstract][Full Text] [Related]
7. SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.
Italiano A; Chen CL; Sung YS; Singer S; DeMatteo RP; LaQuaglia MP; Besmer P; Socci N; Antonescu CR
BMC Cancer; 2012 Sep; 12():408. PubMed ID: 22974104
[TBL] [Abstract][Full Text] [Related]
8. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors.
Gaal J; Stratakis CA; Carney JA; Ball ER; Korpershoek E; Lodish MB; Levy I; Xekouki P; van Nederveen FH; den Bakker MA; O'Sullivan M; Dinjens WN; de Krijger RR
Mod Pathol; 2011 Jan; 24(1):147-51. PubMed ID: 20890271
[TBL] [Abstract][Full Text] [Related]
9. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
[TBL] [Abstract][Full Text] [Related]
10. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis.
Mason EF; Hornick JL
Mod Pathol; 2013 Nov; 26(11):1492-7. PubMed ID: 23743927
[TBL] [Abstract][Full Text] [Related]
11. A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.
Elston MS; Sehgal S; Dray M; Phillips E; Conaglen JV; Clifton-Bligh RJ; Gill AJ
J Clin Endocrinol Metab; 2017 May; 102(5):1447-1450. PubMed ID: 28324028
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
13. Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Dwight T; Benn DE; Clarkson A; Vilain R; Lipton L; Robinson BG; Clifton-Bligh RJ; Gill AJ
Am J Surg Pathol; 2013 Feb; 37(2):226-33. PubMed ID: 23060355
[TBL] [Abstract][Full Text] [Related]
14. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.
Miettinen M; Wang ZF; Sarlomo-Rikala M; Osuch C; Rutkowski P; Lasota J
Am J Surg Pathol; 2011 Nov; 35(11):1712-21. PubMed ID: 21997692
[TBL] [Abstract][Full Text] [Related]
15.
Schipani A; Nannini M; Astolfi A; Pantaleo MA
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980917
[TBL] [Abstract][Full Text] [Related]
16. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
[TBL] [Abstract][Full Text] [Related]
17. Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT.
Dubova M; Sedivcova M; Michal M; Kokoskova B; Ryska A; Smid D; Daum O
Histol Histopathol; 2015 Feb; 30(2):223-32. PubMed ID: 25205505
[TBL] [Abstract][Full Text] [Related]
18. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
19. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor With SDHC Germline Mutation and Bilateral Renal and Neck Cysts.
Stanley K; Friehling E; Davis A; Ranganathan S
Pediatr Dev Pathol; 2019; 22(3):265-268. PubMed ID: 30301441
[TBL] [Abstract][Full Text] [Related]
20. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
